Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GeoVax Labs (GOVX)
NASDAQ:GOVX
GeoVax Labs (GOVX) Stock Price & Analysis
314 Followers
GOVX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.38 - $10.23
Previous Close$1.48
Volume39.98K
Average Volume (3M)100.58K
Market Cap
$3.92M
Enterprise Value-$2.70M
Total Cash (Recent Filing)$6.45M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta4.55
Next Earnings
Aug 13, 2024EPS Estimate
-$5.82Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-14.45
Shares Outstanding2,308,309
10 Day Avg. Volume309,072
30 Day Avg. Volume100,576
Standard Deviation0.46
R-Squared0.13
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.17
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GeoVax Labs News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GOVX FAQ
What was GeoVax Labs’s price range in the past 12 months?
GeoVax Labs lowest stock price was $1.38 and its highest was $10.23 in the past 12 months.
What is GeoVax Labs’s market cap?
Currently, no data Available
When is GeoVax Labs’s upcoming earnings report date?
GeoVax Labs’s upcoming earnings report date is Aug 13, 2024 which is in 61 days.
How were GeoVax Labs’s earnings last quarter?
GeoVax Labs released its earnings results on May 02, 2024. The company reported -$2.47 earnings per share for the quarter, beating the consensus estimate of -$5.56 by $3.09.
Is GeoVax Labs overvalued?
According to Wall Street analysts GeoVax Labs’s price is currently Overvalued.
Does GeoVax Labs pay dividends?
GeoVax Labs does not currently pay dividends.
What is GeoVax Labs’s EPS estimate?
GeoVax Labs’s EPS estimate is -$5.82.
How many shares outstanding does GeoVax Labs have?
GeoVax Labs has 2,528,309 shares outstanding.
What happened to GeoVax Labs’s price movement after its last earnings report?
GeoVax Labs reported an EPS of -$2.47 in its last earnings report, beating expectations of -$5.56. Following the earnings report the stock price went down -2.069%.
Which hedge fund is a major shareholder of GeoVax Labs?
Currently, no hedge funds are holding shares in GOVX
---
GeoVax Labs Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-81.90%
12-Months-Change
Fundamentals
Return on Equity
-242.41%
Trailing 12-Months
Asset Growth
-87.75%
Trailing 12-Months
Company Description
GeoVax Labs
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and cancer using its novel vaccine platform. It focuses on human immunodeficiency virus, zika virus, hemorrhagic fever viruses, and malaria. The company was founded by Harriet Latham Robinson and Donald G. Hildebrand on September 9, 2006 and is headquartered in Smyrna, GA.
---
GOVX Earnings Call
Q4 2024
0:00 / 0:00
---
GOVX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering GOVX
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-70.16%
reiterated a buy rating 7 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -70.16% per trade.
---